Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Psilocybin in Cancer Pain Study
Yvan Beaussant, MD, MSci
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Rush University Medical Center
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Sharmin Ghaznavi
Imaging Depression in Parkinson's Disease
Yale University
Tolerability of MDMA in Schizophrenia
Anya Bershad, MD, PhD
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Dr. Inge Winter
Psilocybin Therapy for Depression in Parkinson's Disease
Joshua Woolley, MD, PhD
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
GH Research Ireland Limited
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
4th Military Clinical Hospital with Polyclinic, Poland
Low-Dose Ketamine Infusion During Burn Wound Care
University of Tennessee
Lysergic Acid Diethylamide (LSD) in Palliative Care
University Hospital, Basel, Switzerland
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
University of Rochester
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
University Hospital, Ghent
Effect of Opioid-Free vs Opioid-Based Anesthesia on Postoperative Pain and Emergence Agitation in Children Undergoing Cleft Surgery
Iva Smiljanić
Belief Updating in Treatment Resistant Depression
Assistance Publique - Hôpitaux de Paris
The Impact of Psilocybin on Pain in Fibromyalgia Patients
Maastricht University
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Melt Pharmaceuticals
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
Antonios Likourezos
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Lindsay Maguire, MD
Pharmacologic Treatment Augmentation in Chronic Depression
University Hospital Tuebingen
Psilocybin in Chronic Low Back Pain and Depression
Johns Hopkins University
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Section for Affective Disorders; Northern Stockholm Psychiatry
MDMA for Co-occurring PTSD and OUD After Childbirth
University of New Mexico
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
Non-steroidal Anti-inflammatory in Cardiac Surgery
Centre Hospitalier Universitaire, Amiens
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
University of Calgary
Opioid-free Anesthesia as an Alternative to General Anesthesia in Abdominal Surgery
Jagiellonian University
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
University of California, Berkeley
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Reinier de Graaf Groep
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Stanford University
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Brugmann University Hospital
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Johns Hopkins University
MDMA for AUD/PTSD Comorbidity
Carolina L Haass-Koffler
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Dr. med. Marcus Herdener
Neural Circuit Effects of Ketamine in Depression
Icahn School of Medicine at Mount Sinai
The OBSERVE Protocol
Yale University
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Evaluation of the Stress Response in Anesthesia Use Inhalation Anesthetic (Desflurane) Versus TIVA for Bariatric Surgery
G.Gennimatas General Hospital
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
University Health Network, Toronto
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
Etomidate Versus Propofol in CABG Surgery
Hartford Hospital
Effect of Ketamine on Intraoperative Motor Evoked Potentials
University of California, San Francisco
Prehospital Analgesia INtervention Trial (PAIN)
Jason Sperry
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Johns Hopkins University
Psilocybin-facilitated Treatment for Chronic Pain
University of Alabama at Birmingham
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Biogen
HNC: Human Neural Circuits Electrophysiology During Cognition
Stanford University
RIVER At Home Ketamine Protocols
RIVER Foundation
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.